Escaping Deleterious Immune Response in Their Hosts: Lessons from Trypanosomatids, Front Immunol, vol.7, pp.1-21, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01512013
,
, Trypanosomatid Infections: How Do Parasites and Their Excreted-Secreted Factors Modulate the Inducible Metabolism of l-Arginine in Macrophages? Front Immunol. Frontiers, vol.9, p.778, 2018.
, Oral Presentation Sessions, Trop Med Int Heal, vol.22, pp.2-114, 2017.
Challenges in visceral leishmaniasis control and elimination in the developing countries: A review, 2016. ,
Social and Economic Burden of Human Leishmaniasis, Am J Trop Med Hyg ,
, The American Society of Tropical Medicine and Hygiene, vol.94, issue.3, pp.489-93, 2016.
Recent updates and perspectives on leishmaniasis, J Infect Dev Ctries, vol.9, issue.06, pp.588-96, 2015. ,
Cutaneous leishmaniasis and conflict in Syria, Emerg Infect Dis, vol.22, 2016. ,
Old World cutaneous leishmaniasis and refugee crisis in the Middle East and North Africa, PLoS Negl Trop Dis, vol.10, 2016. ,
A review of visceral leishmaniasis during the conflict in South Sudan and the consequences for East African countries. Parasites and Vectors, vol.9, 2016. ,
Cutaneous Leishmaniasis in Syria: Clinical Features, Current Status and the Effects of War, Acta Derm Venereol, vol.95, issue.1, pp.62-68, 2015. ,
Weekly epidemiological record: Global leishmaniasis update, World Heal Organ, vol.92, issue.38, pp.557-72, 2006. ,
, The Lancet, vol.392, pp.951-70, 2018.
Accelerating Work to Overcome the Global Impact of Neglected Tropical Diseases: A Roadmap for Implementation. World Health Organization, 2012. ,
, The Sixtieth World Health Assembly. Resolution WHA60.13 Control of leishmaniasis. 2007. 15. Lacerda MM. The Brazilian Leishmaniasis Control Program, Mem Inst Oswaldo Cruz, 1994.
, The Lancet, vol.392, pp.951-70, 2018.
, Leishmania Species: Visceral (Kala-Azar)
,
, Bennett's Principles and Practice of Infectious Diseases, pp.3493-525, 2015.
The immunology of post-kala-azar dermal leishmaniasis (PKDL). Parasit Vectors, BioMed Central, vol.9, issue.1, p.464, 2016. ,
A Historical Overview of the Classification, Evolution, and Dispersion of Leishmania Parasites and Sandflies, PLoS Negl Trop Dis. Public Library of Science, vol.10, issue.3, p.4349, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01947736
Some epidemiological consequences of the evolutionary fit between Leishmaniae and their phlebotomine vectors, Bull Soc Pathol Exot Filiales, vol.78, issue.5, pp.747-55, 1985. ,
Chapter 14 -Proteomics Advances in the Study of Leishmania Parasites and Leishmaniasis, Proteins and Proteomics of Leishmania and Trypanosoma, pp.323-372, 2014. ,
Protein turnover and differentiation in Leishmania, Int J Parasitol, vol.37, issue.10, pp.1063-75, 2007. ,
The genome of the kinetoplastid parasite, Leishmania major, Science, vol.309, issue.5733, pp.436-478, 2005. ,
Genomic and proteomic expression analysis of Leishmania promastigote and amastigote life stages: The Leishmania genome is constitutively expressed, Mol Biochem Parasitol, vol.152, issue.1, pp.35-46, 2007. ,
The Leishmania proteome, Leishmania, 2008. ,
Comparative genomic analysis of three Leishmania species that cause diverse human disease, Nat Genet, vol.39, issue.7, pp.839-886, 2007. ,
URL : https://hal.archives-ouvertes.fr/hal-00169316
Chromosome and multitasking, Biochim Biophys Acta -Mol Cell Res, vol.1803, issue.4, pp.520-525, 2010. ,
MoonProt 2.0: an expansion and update of the moonlighting proteins database, Nucleic Acids Res. Narnia, vol.46, issue.D1, pp.640-644, 2018. ,
Identification of virulence factors in leishmania infantum strains by a proteomic approach, J Proteome Res, vol.13, issue.4, pp.1860-72, 2014. ,
Genetic complementation of Leishmania deficient in PSA (GP46) restores their resistance to lysis by complement, Mol Biochem Parasitol, vol.137, issue.1, pp.185-194, 2004. ,
Upregulation of surface proteins in Leishmania donovani isolated from patients of post kala-azar dermal leishmaniasis, Microbes Infect, vol.8, issue.3, pp.637-681, 2006. ,
Attenuation of gamma interferon-induced tyrosine phosphorylation in mononuclear phagocytes infected with Leishmania donovani: selective inhibition of signaling through Janus kinases and Stat1, Infect Immun. American Society for Microbiology Journals, vol.63, issue.11, pp.4495-500, 1995. ,
Characterisation and expression of a stage-regulated gene of Leishmania major, Mol Biochem Parasitol, vol.76, issue.1-2, pp.201-214, 1996. ,
Prediction of T Cell Epitopes from Leishmania major Potentially Excreted/Secreted Proteins Inducing Granzyme B Production ,
URL : https://hal.archives-ouvertes.fr/hal-01356501
Immunoprotective responses of T helper type 1 stimulatory protein-S-adenosyl-L-homocysteine hydrolase against experimental visceral leishmaniasis, Clin Exp Immunol. Wiley-Blackwell, vol.185, issue.2, pp.165-79, 2016. ,
Leishmania virulence factors: Focus on the metalloprotease GP63, Microbes Infect, vol.14, issue.15, pp.1377-89, 2012. ,
Enolase: a key player in the metabolism and a probable virulence factor of trypanosomatid parasites-perspectives for its use as a therapeutic target, Enzyme Res. Hindawi Limited, p.932549, 2011. ,
Functional analysis of Leishmania major cyclophilin, Int J Parasitol. NIH Public Access, vol.38, issue.6, pp.633-642, 2008. ,
Identification of leishmania fructosedomain containing protein tyrosine phosphatase SHP-1, Biochem Biophys Res Commun, vol.364, issue.3, pp.601-608, 2007. ,
Better Than Nothing? Limitations of the Prediction Tool SecretomeP in the Search for Leaderless Secretory Proteins (LSPs) in Plants, Front Plant Sci. Frontiers, vol.7, p.1451, 2016. ,
Predicting eukaryotic protein secretion without signals, Biochim Biophys Acta -Proteins Proteomics, 2018. ,
Shedding light on the cell biology of extracellular vesicles, Nat Rev Mol Cell Biol. Nature Publishing Group, vol.19, issue.4, pp.213-241, 2018. ,
Vaccines for visceral leishmaniasis: A review, J Immunol Methods, vol.422, pp.1-12, 2015. ,
Leishmaniasis: Vaccine candidates and perspectives, Vaccine. Elsevier Ltd, vol.30, issue.26, pp.3834-3876, 2012. ,
Contribution of proteomics of Leishmania spp. to the understanding of differentiation, drug resistance mechanisms, vaccine and drug development, J Proteomics, vol.74, issue.9, pp.1614-1638, 2011. ,
, Janeway's Immunobiology
Leishmaniasis: Vaccine candidates and perspectives, Vaccine. Elsevier Ltd, vol.30, issue.26, pp.3834-3876, 2012. ,
Vaccines to prevent leishmaniasis, Clin Transl Immunol. Nature Publishing Group, vol.3, issue.3, p.13, 2014. ,
Leishmania genome analysis and high-throughput immunological screening identifies tuzin as a novel vaccine candidate against visceral leishmaniasis, Vaccine. Elsevier Ltd, vol.32, issue.30, pp.3816-3838, 2014. ,
Identifying vaccine targets for anti-leishmanial vaccine development, Expert Rev Vaccines, vol.13, issue.4, pp.489-505, 2014. ,
Case study for a vaccine against leishmaniasis. Vaccine, vol.31, pp.244-253, 2013. ,
Identification of broadly conserved cross-species protective Leishmania antigen and its responding CD4 + T cells, Sci Transl Med, vol.7, issue.310, pp.1-13, 2015. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01375023
Transcriptomics throughout the life cycle of Leishmania infantum: High down-regulation rate in the amastigote stage, Int J Parasitol, vol.40, issue.13, pp.1497-516, 2010. ,
Leishmania infantum released proteins specifically regulate cytokine expression and production patterns by CD4+ and CD8+ T cells, Acta Trop, vol.97, issue.3, pp.309-326, 2006. ,
Secreted virulence factors and immune evasion in visceral leishmaniasis, J Leukoc Biol, vol.91, issue.6, pp.887-99, 2012. ,
Leishmania infantum: Soluble proteins released by the parasite exert differential effects on host immune response, Exp Parasitol, vol.109, issue.2, pp.106-120, 2005. ,
Identification of Th1-responsive leishmanial excretory-secretory antigens (LESAs), Exp Parasitol. Elsevier Inc, vol.132, issue.3, pp.355-61, 2012. ,
Insights on adaptive and innate immunity in canine leishmaniosis, 2019. ,
Stage-specific CHAPTER ,
, differential gene expression in Leishmania infantum: from the foregut of Phlebotomus perniciosus to the human phagocyte, BMC Genomics. BioMed Central
An Introduction to Sequence Similarity, Homology ") Searching. Curr Protoc Bioinforma, pp.1-9, 2013. ,
Diagnostic Peptide Discovery: Prioritization of Pathogen Diagnostic Markers Using Multiple Features, PLoS One, vol.7, issue.12, p.50748, 2012. ,
Evaluation of a Leishmania hypothetical protein administered as DNA vaccine or recombinant protein against Leishmania infantum infection and its immunogenicity in humans, Cell Immunol, vol.331, pp.67-77, 2018. ,
, Janeway's Immunobiology, pp.818-54, 2017.
Properties of MHC Class I Presented Peptides That Enhance Immunogenicity, PLoS Comput Biol. Public Library of Science, vol.9, issue.10, p.1003266, 2013. ,
6 CD8 T-cell Immunodominance, Repertoire, and Memory, pp.109-144, 2006. ,
Major histocompatibility complex linked databases and prediction tools for designing vaccines, Hum Immunol, vol.77, issue.3, pp.295-306, 2016. ,
The immune epitope database (IEDB) 3.0. Nucleic Acids Res, vol.43, pp.405-417, 2015. ,
, Immunological Bioinformatics. Methods. Cambridge, 2005.
Immuno-informatics: A Brief Review, Immunoinformatics. Methods in Molecular Biology (Methods and Protocols), vol.1184, 2014. ,
Structural and Computational Biology in the Design of Immunogenic Vaccine Antigens, J Immunol Res, p.156241, 2015. ,
Chapter 6 -Databases for T-Cell Epitopes, Immunoinformatics, pp.123-157, 2014. ,
Design and utilization of epitope-based databases and predictive tools ,
The Immune Epitope Database: How Data Are Entered and Retrieved, J Immunol Res, 2017. ,
The Immune Epitope Database (IEDB): 2018 update, Nucleic Acids Res, vol.47, issue.D1, pp.339-382, 2019. ,
IPD-the Immuno Polymorphism Database, Nucleic Acids Res. Narnia, vol.41, issue.D1, pp.1234-1274, 2012. ,
The IMGT/HLA database, Nucleic Acids Res, vol.41, issue.D1, pp.1222-1229, 2012. ,
MHCPEP: a database of MHC-binding peptides, Nucleic Acids Res, vol.22, issue.17, pp.3663-3668, 1994. ,
SYFPEITHI: database for MHC ligands and peptide motifs, Immunogenetics, vol.50, pp.213-222, 1999. ,
MHCBN 4.0: A database of MHC/TAP binding peptides and Tcell epitopes, BMC Res Notes, vol.2, p.61, 2009. ,
Immunoinformatics and epitope prediction in the age of next-generation sequencing and personalized medicine, Genome Med. Genome Medicine, pp.1-12, 2015. ,
State of the art and challenges in sequence based Tcell epitope prediction, Immunome Res, vol.6, issue.2, p.3, 2010. ,
Chapter 19 -T-Cell Epitope Prediction Methods: An Overview, Immunoinformatics Methods in Molecular Biology (Methods and Protocols), 2014. ,
, Principles and Practice. Vaccinology: Principles and Practice, 2012.
Peptide binding predictions for HLA DR, DP and DQ molecules, BMC Bioinformatics, vol.11, issue.1, p.568, 2010. ,
Toward more accurate pan-specific MHC-peptide binding prediction: A review of current methods and tools. Brief Bioinform, vol.13, pp.350-64, 2012. ,
Evaluation of MHC-II peptide binding prediction servers: applications for vaccine research, BMC Bioinformatics, vol.9, p.22, 2008. ,
A Systematic Assessment of MHC Class II Peptide Binding Predictions and Evaluation of a Consensus Approach, PLoS Comput Biol, vol.4, issue.4, p.1000048, 2008. ,
A Community Resource Benchmarking Predictions of Peptide Binding to MHC-I Molecules, PLoS Comput Biol. Public Library of Science, vol.2, issue.6, p.65, 2006. ,
Automated benchmarking of peptide-MHC class I binding predictions, Bioinformatics, vol.31, issue.13, pp.2174-2181, 2015. ,
A consensus strategy for combining HLA-DR binding algorithms, Hum Immunol, vol.64, issue.9, pp.852-858, 2003. ,
Peptide-based vaccinology: experimental and computational approaches to target hypervariable viruses through the fine characterization of protective epitopes recognized by monoclonal antibodies and the identification of T-cell-activating peptides, Clin Dev Immunol, 2013. ,
Cooperativity of hydrophobic anchor interactions: evidence for epitope selection by MHC class II as a folding process, J Immunol, vol.178, issue.11, pp.7181-7190, 2007. ,
Reverse Vaccinology: Developing Vaccines in the Era of, Genomics. Immunity, vol.33, issue.4, pp.530-571, 2010. ,
Proteome Data Sets: A Comprehensive Resource for Vaccine Development to, Target Visceral Leishmaniasis. Front Immunol. Frontiers, vol.5, p.260, 2014. ,
Cross-presentation: underlying mechanisms and role in immune surveillance, Immunol Rev, vol.207, issue.1, pp.166-83, 2005. ,
,
, Computer-aided biotechnology: from immuno-informatics to reverse vaccinology, Trends Biotechnol, vol.26, issue.4, pp.190-200, 2008.
An assessment on epitope prediction methods for protozoa genomes, BMC Bioinformatics, vol.13, issue.1, p.309, 2012. ,
Immune camouflage: Relevance to vaccines and human immunology, Hum Vaccin Immunother, vol.10, issue.12, pp.3570-3575, 2015. ,
First generation leishmaniasis vaccines: A review of field efficacy trials, Vaccine, vol.26, issue.52, pp.6759-67, 2008. ,
T cell epitope: Friend or Foe? Immunogenicity of biologics in context, Adv Drug Deliv Rev, vol.61, issue.11, pp.965-76, 2009. ,
Challenges in validating candidate therapeutic targets in cancer, Elife. eLife Sciences Publications Limited, vol.7, p.32402, 2018. ,
Challenges and responses in human vaccine development, Curr Opin Immunol, vol.28, pp.18-26, 2014. ,
Systems vaccinology: Enabling rational vaccine design with systems biological approaches, Vaccine, vol.33, issue.40, pp.5294-301, 2015. ,
Immunodominance in major histocompatibility complex class Irestricted T lymphocyte responses, Annu Rev Immunol, vol.17, pp.51-88, 1999. ,
The kinetic stability of MHC class II:peptide complexes is a key parameter that dictates immunodominance, Immunity, vol.23, issue.1, pp.29-40, 2005. ,
The relationship between immunodominance, DM editing, and the kinetic stability of MHC class II:peptide complexes, Immunol Rev, vol.207, issue.1, pp.261-78, 2005. ,
Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8 + T cells, 2013. ,
Functional classification of class II human leukocyte antigen (HLA) molecules reveals seven different supertypes and a surprising degree of repertoire sharing across supertypes, Immunogenetics, 2011. ,
Peptide presentation by HLA-DQ molecules is associated with the development of immune tolerance, PeerJ. PeerJ, Inc, vol.6, p.5118, 2018. ,
Clinical validation of the "in silico" prediction of immunogenicity of a human recombinant therapeutic protein, Clin Immunol, vol.124, issue.1, pp.26-32, 2007. ,
NetMHCpan-4.0: Improved Peptide-MHC Class I Interaction Predictions Integrating Eluted Ligand and Peptide Binding Affinity Data, J Immunol, vol.199, issue.9, pp.3360-3368, 2017. ,
A consensus epitope prediction approach identifies the breadth of murine TCD8+-cell responses to vaccinia virus, Nat Biotechnol, vol.24, issue.7, pp.817-826, 2006. ,
Accurate pan-specific prediction of peptide-MHC class II binding affinity with improved binding core identification, Immunogenetics. NIH Public Access, vol.67, pp.641-50, 2015. ,
ProPAS: standalone software to analyze protein properties, Bioinformation ,
, Biomedical Informatics Publishing Group, vol.8, issue.3, pp.167-176, 2012.
BLAST: At the core of a powerful and diverse set of sequence analysis tools, Nucleic Acids Res, vol.32, pp.20-25, 2004. ,
A Reverse Vaccinology Approach for the Identification of Potential Vaccine Candidates from Leishmania spp, Appl Biochem Biotechnol, vol.167, issue.5, pp.1340-50, 2012. ,
Mining the Leishmania genome for novel antigens and vaccine candidates, Proteomics, vol.9, issue.5, pp.1293-301, 2009. ,
Computational tools for epitope vaccine design and evaluation, Curr Opin Virol, vol.11, pp.103-115, 2015. ,
Experimental validation of multi-epitope peptides including promising MHC class I-and II-restricted epitopes of four known Leishmania infantum proteins, Front Immunol, vol.5, pp.1-16, 2014. ,
In vitro evaluation of a soluble Leishmania promastigote surface antigen as a potential vaccine candidate against human leishmaniasis, PLoS One, vol.9, issue.5, pp.1-12, 2014. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01098532
,
Identification and characterization of new Leishmania promastigote surface antigens, LaPSA-38S and LiPSA-50S, as major immunodominant excreted/secreted components of L. amazonensis and L. infantum, Recombinant Forms of Leishmania amazonensis Excreted/Secreted Promastigote Surface Antigen (PSA) Induce Protective Immune Responses in Dogs, vol.10, pp.1-14, 2014. ,
HLA class I alleles are associated with peptide binding repertoires of different size, affinity and immunogenicity, vol.191, pp.6-10, 2014. ,
T cell epitope: Friend or Foe? Immunogenicity of biologics in context, Adv Drug Deliv Rev, vol.61, issue.11, pp.965-76, 2009. ,
T-cell dependent immunogenicity of protein therapeutics: Preclinical assessment and mitigation, Clin Immunol, vol.149, issue.3, pp.534-55, 2013. ,
A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assays, J Immunol Methods, vol.260, issue.1-2, pp.157-72, 2002. ,
, Standardizing Flow Cytometry Immunophenotyping Analysis from the Human ImmunoPhenotyping Consortium
, Nat Publ Gr, 2016.
High Throughput T Epitope Mapping and Vaccine Development, J Biomed Biotechnol, vol.2010, pp.1-12, 2010. ,
Miniaturized and highthroughput assays for analysis of T-cell immunity specific for opportunistic pathogens and HIV. Clin Vaccine Immunol, vol.21, pp.488-95, 2014. ,
Activation-induced expression of CD137 permits detection, isolation, and expansion of the full repertoire of CD8+ T cells responding to antigen without requiring knowledge of epitope specificities, Blood, vol.110, issue.1, pp.201-211, 2007. ,
Quantitative analysis of the CD4 T-cell repertoire specific to therapeutic antibodies in healthy donors, FASEB J, vol.25, issue.6, pp.2040-2048, 2011. ,
Differential capacity of T cell priming in naive donors of promiscuous CD4+ T cell epitopes of HCV NS3 and Core proteins, Eur J Immunol, vol.37, issue.6, pp.1513-1536, 2007. ,
The Tumor Antigen Cyclin B1 Hosts Multiple CD4 T Cell Epitopes Differently Recognized by Pre-Existing Naive and Memory Cells in Both Healthy and Cancer Donors, J Immunol, issue.195, pp.1891-901, 2015. ,
In vitro methods for generating CD8+ Tcell clones for immunotherapy from the naïve repertoire, J Immunol Methods, vol.310, issue.1-2, pp.40-52, 2006. ,
,
Human naive and memory CD4 + T cell repertoires specific for naturally processed antigens analyzed using libraries of amplified T cells, J Exp Med, vol.206, issue.7, pp.1525-1559, 2009. ,
, Janeway's Immunobiology, pp.818-54, 2017.
Endogenous Naive CD8+ T Cell Precursor Frequency Regulates Primary and Memory Responses to Infection, Immunity. Cell Press, vol.28, issue.6, pp.859-69, 2008. ,
Pooled-Peptide Epitope Mapping Strategies Are Efficient and Highly Sensitive: An Evaluation of Methods for Identifying Human T Cell Epitope Specificities in Large-Scale HIV Vaccine Efficacy Trials, vol.11, p.147812, 2016. ,
Antigen-specific activation and cytokine-facilitated expansion of naive, human CD8+ T cells, Nat Protoc, vol.9, issue.4, pp.950-66, 2014. ,
Immunoprevalence of the CD4+ T-cell response to HIV Tat and Vpr proteins is provided by clustered and disperse epitopes, respectively, Eur J Immunol, vol.38, issue.10, pp.2821-2852, 2008. ,
URL : https://hal.archives-ouvertes.fr/hal-00334819
,
, Allele frequency net 2015 update: new features for HLA epitopes, KIR and disease and HLA adverse drug reaction associations, Nucleic Acids Res, vol.43, issue.D1, pp.784-792, 2015.
Allele Frequencies Net Database: Improvements for storage of individual genotypes and analysis of existing data, Hum Immunol, vol.77, issue.3, pp.238-286, 2016. ,
HLA class I supertypes: a revised and updated classification, BMC Immunol, vol.9, p.1, 2008. ,
CD4 T cells specific for factor VIII are present at high frequency in healthy donors and comprise naïve and memory cells, Blood Adv, vol.1, issue.21, pp.1842-1849, 2017. ,
Characterization of CD4 T Cell Epitopes of Infliximab and Rituximab Identified from Healthy Donors, Front Immunol, vol.8, p.500, 2017. ,
Hierarchy of CD4 T Cell Epitopes of the ANRS Lipo5 Synthetic Vaccine Relies on the Frequencies of Pre-Existing Peptide-Specific T Cells in Healthy Donors, J Immunol, vol.190, pp.5757-63, 2013. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01109463
The Role of Naive T Cell Precursor Frequency and Recruitment in dictating Immune Response Magnitude", J Immunol Ref J Immunol Clin Immunol Eur J Immunol Cancer Immunol Immunother, vol.190, issue.56, pp.2404-2415, 2013. ,
Considerations for optimization and validation of an in vitro PBMC derived T cell assay for immunogenicity prediction of biotherapeutics, Clin Immunol, vol.137, pp.5-14, 2010. ,
,
, Maturation pathways of dendritic cells determine TAP1 and TAP2 levels and crosspresenting function, J Immunother. NIH Public Access, vol.32, issue.5, pp.465-73, 2009.
Peptide-Pulsed Dendritic Cells Have Superior Ability to Induce Immune-Mediated Tissue Destruction Compared to Peptide with Adjuvant ,
Optimization of a dendritic cell-based assay for the in vitro priming of naive human CD4+ T cells, J Immunol Methods. Elsevier B.V, vol.353, issue.1-2, pp.8-19, 2010. ,
The Density of Peptides Displayed by Dendritic Cells Affects Immune Responses to Human Tyrosinase and gp100 in HLA-A2 Transgenic Mice, J Immunol. American Association of Immunologists, vol.164, issue.5, pp.2354-61, 2014. ,
High Frequencies of Naive Melan-a/Mart-1-Specific Cd8+ T Cells in a Large Proportion of Human ,
Hla)-A2 Individuals, J Exp Med, vol.190, issue.5, pp.705-721, 1999. ,
A Shift in the Phenotype of Melan-A-Specific CTL Identifies Melanoma Patients with an Active Tumor-Specific Immune Response, J Immunol, vol.165, issue.11, pp.6644-52, 2014. ,
Cutaneous leishmaniasis in North Africa: a review, Parasite, vol.21, p.14, 2014. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01098542
Ecological Niche Modeling for the Prediction of the Geographic Distribution of Cutaneous Leishmaniasis in Tunisia, Am J Trop Med Hyg, vol.94, issue.4, pp.844-51, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01356536
,
Extensive HLA class I allele promiscuity among viral CTL epitopes, Eur J Immunol, vol.37, issue.9, pp.2419-2452, 2007. ,
Extensive major histocompatibility complex class I binding promiscuity for Mycobacterium tuberculosis TB10.4 peptides and immune dominance of human leucocyte antigen ,
Ltd (10.1111), 0801 alleles in TB10.4 CD8+ T-cell responses. Immunology, vol.129, pp.496-505, 2010. ,
The blockade of immune checkpoints in cancer immunotherapy, Nat Rev Cancer, vol.12, issue.4, pp.252-64, 2012. ,
Blockade of CTLA-4 enhances host resistance to the intracellular pathogen, Leishmania donovani, J Immunol, vol.161, issue.8, pp.4153-60, 1998. ,
PD-1 function in apoptosis of T lymphocytes in canine visceral leishmaniasis, Immunobiology. Urban & Fischer, vol.221, issue.8, pp.879-88, 2016. ,
Modulation of T-Cell Costimulation as Immunotherapy or Immunochemotherapy in Experimental Visceral Leishmaniasis, Infect Immun, vol.71, issue.11, pp.6453-62, 2003. ,
Peptide Dose and/or Structure in Vaccines as a Determinant of T Cell Responses. Vaccines. Multidisciplinary Digital Publishing Institute, vol.2, pp.537-585, 2014. ,
Human memory T cells: generation, compartmentalization and homeostasis, Nat Rev Immunol, vol.14, issue.1, pp.24-35, 2014. ,
Activation, dysfunction and retention of T cells in vaccine sites after injection of incomplete Freund's adjuvant, with or without peptide, Cancer Immunol Immunother, vol.62, issue.7, pp.1149-59, 2009. ,
2 scars (abdomen, foot), Age, vol.45 ,